Parenteral Drugs (India) Limited (IN:PDPL)
:PDPL
PDPL Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
PDPL FAQ
What was Parenteral Drugs (India) Limited’s price range in the past 12 months?
Currently, no data Available
What is Parenteral Drugs (India) Limited’s market cap?
Parenteral Drugs (India) Limited’s market cap is ₹101.08M.
When is Parenteral Drugs (India) Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Parenteral Drugs (India) Limited’s earnings last quarter?
Currently, no data Available
Is Parenteral Drugs (India) Limited overvalued?
According to Wall Street analysts Parenteral Drugs (India) Limited’s price is currently Overvalued.
Does Parenteral Drugs (India) Limited pay dividends?
Parenteral Drugs (India) Limited pays a Notavailable dividend of $1.125 which represents an annual dividend yield of N/A. See more information on Parenteral Drugs (India) Limited dividends here
What is Parenteral Drugs (India) Limited’s EPS estimate?
Parenteral Drugs (India) Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Parenteral Drugs (India) Limited have?
Parenteral Drugs (India) Limited has 29,816,300 shares outstanding.
What happened to Parenteral Drugs (India) Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Parenteral Drugs (India) Limited?
Currently, no hedge funds are holding shares in IN:PDPL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Parenteral Drugs (India) Limited
Parenteral Drugs (India) Limited operates as an India-based healthcare enterprise, specializing in the production of a diverse range of pharmaceutical goods. Its offerings encompass various medicinal products, including intravenous and inhalation therapies, as well as veterinary infusions. The company's extensive product portfolio further comprises various intravenous (IV) solutions, such as those containing carbohydrates and electrolytes, diuretics, and solutions for dialysis and irrigation. Additionally, they provide anti-infective, anti-fungal, oncology, and anesthesia medications. The firm maintains a significant international presence, exporting its goods to numerous nations including Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. Established in 1983, Parenteral Drugs (India) Limited's operations are headquartered in Indore, India.
Gland Pharma Ltd.
―
IPCA Laboratories Limited
―
JB Chemicals & Pharmaceuticals Ltd.
―
Strides Pharma Science Ltd
―
Wockhardt Limited
―